ARCHIVES

DCT Board Sends Message On Cutting Grants to Extend Paylines, Then Tries To Take It Back

This article is from The Cancer Letter archive.

Vol. 10 No. 09 | March 2, 1984

Download PDF Visit The Full Archive

Related Articles

Rituximab Maintenance Improves Survival In Relapse

February 27, 2009

NCI R01 Payline Stays At 12th Percentile for FY07.

February 9, 2007

Pragmatists vs. Purists: Colon Cancer Screening Guideline Triggers Debate.

October 10, 2008

FDA Opponents Claim Abuses; Agency Doesn’t Attend Hearing

July 28, 1995

NCI-Approved Trials Listed

April 28, 2006

FDA Announces Plan to Reform Drug Approval, Hire Outside Experts To Handel Some Reviews

November 22, 1991